Sort
64,565 grants matching “drug discovery”
UC San Diego Clinical and Translational Research Institute
$667,191Colin A Depp · University Of California, San Diego · TL1 · FY2017 · TR
Host determinants of protection against tuberculosis in adolescents
$667,142Willem Albert Hanekom · University Of Cape Town · R01 · FY2012 · AI
Novel molecular therapeutics for cystic fibrosis
$667,073David E Sterner · Progenra, Inc. · R44 · FY2015 · HL
The Tisch Cancer Institute (TCI) Paul Calabresi K12 Career Development Award for Clinical Oncology
$666,985Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · K12 · FY2025 · CA
Project 1
$666,939John D Gross · University Of California, San Francisco · U54 · FY2025 · AI
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$666,928Paul S Mischel · Stanford University · R01 · FY2023 · CA
Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation
$666,882Suhas Kallapur · University Of California Los Angeles · R01 · FY2025 · HD
High-Throughput Solid-Phase Combinatorial Biocatalysis
$666,837Jonathan S. Dordick · Rensselaer Polytechnic Institute · R01 · FY2006 · GM
Administrative Core
$666,812Robert E. Lewis · University Of Nebraska Medical Center · P20 · FY2020 · GM
Multiplexed Measurement of Psychoactive Drug Selectivity Profiles
$666,789Peter Krutzik · Primity, Inc. · R44 · FY2011 · DA
Remediating fibrosis for salivary gland regeneration
$666,773Melinda Larsen · State University Of New York At Albany · R01 · FY2025 · DE
M1 PAMs for Age-Related Cognitive Impairments
$666,679Carrie Kimberly Jones · Vanderbilt University · R01 · FY2020 · AG
Lab Research Training in Pediatric Oncology-Hematology
$666,679Alan D Friedman · Johns Hopkins University · T32 · FY2025 · CA
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
$666,651Todd D Gould · University Of Maryland Baltimore · R01 · FY2024 · MH
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
$666,651Todd D Gould · University Of Maryland Baltimore · R01 · FY2025 · MH
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
$666,651Todd D Gould · University Of Maryland Baltimore · R01 · FY2021 · MH
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug
$666,604Kojo Mensa-Wilmot · Kennesaw State University · R01 · FY2025 · AI
Profiling Ras Activated Signal Transduction Pathways
$666,481University Of California Irvine · R33 · FY2003 · CA
Bloomington Drosophila Stock Center at Indiana University
$666,448Kevin R Cook · Trustees Of Indiana University · P40 · FY2017 · OD
SBIR Phase II: Disposable pL Fluid Transfer/Microarray Printing Device
$666,393Robert C Haushalter · Parallel Synthesis Technologies, Inc · · FY2007 · TIP
Retrovirus Evolution
$666,343John M Coffin · Tufts University Boston · R37 · FY2010 · CA
Nanotherapeutic strategies for the treatment of chronic Chagas Disease
$666,319Evan Alexander Scott · University Of Virginia · R01 · FY2025 · HL
Engineering 3D Osteosarcoma Models to Elucidate Biology and Inform Drug Discovery
$666,209Fan Yang · Stanford University · R01 · FY2023 · CA
Megalencephaly and segmental brain overgrowth in humans
$666,161William B Dobyns · Seattle Children'S Hospital · R01 · FY2017 · NS
Megalencephaly and segmental brain overgrowth in humans
$666,161William B Dobyns · Seattle Children'S Hospital · R01 · FY2016 · NS